When evaluating the datasets of CRPC and NEPC, we found that SLC12A5 expression was significantly upregulated in NEPC and CRPC compared with prostate adenocarcinoma samples (Fig. 3A). The gene discussed is SLC12A5; the disease is prostate adenocarcinoma.